Enacts the "Give Kids a Chance - Carter and Ray's Law" mandating health insurance coverage for congenital anomalies including certain reconstructive services, habilitative services, and inpatient and outpatient services.
S09649, titled the "Give Kids a Chance - Carter and Ray's Law," would require New York health insurance policies, contracts, certificates, and plans to cover treatment for congenital anomalies in dependent children. The bill defines key terms such as congenital anomaly, reconstructive services, habilitative services, cosmetic surgery, and deviation, and specifies that covered treatment includes inpatient and outpatient care intended to improve or restore function or approximate a normal appearance. Covered services would include reconstructive procedures, prosthetics and appliances related to complications, adjunctive dental and orthodontic care, and follow-up or secondary-condition treatment, while excluding cosmetic surgery.
The bill also requires coverage for reconstructive and habilitative services when determined medically necessary by the treating physician, allows standard deductibles, copayments, and coinsurance consistent with other benefits, and prohibits insurers from avoiding the mandate by denying enrollment or renewal or by reducing provider reimbursement. It further requires written notice of the coverage at enrollment and annually thereafter, and it creates an expedited internal appeal process for denials involving congenital anomaly treatment, with an oral decision due within 48 hours and written confirmation within seven days.
The bill would amend multiple sections of the New York Insurance Law, including sections 3216, 4235, 4304, and 4305, to add a uniform coverage mandate for congenital anomaly treatment across different categories of health insurance products. It would expand required benefits to include reconstructive and habilitative services, related dental and prosthodontic care, prosthetics, and other medically necessary services for covered dependent children, while limiting the exclusion to cosmetic surgery. The bill would apply to policies and contracts issued, renewed, modified, altered, or amended on or after the effective date, thereby affecting insurers, health plans, providers, and families seeking coverage for congenital conditions.
The available context suggests generally supportive intent and a child-focused framing, reflected in the bill’s title and its broad coverage mandate for medically necessary treatment. No committee transcript or recorded vote information is provided, so there is no documented opposition or formal vote pattern to assess. Based on the text alone, the bill appears designed to address coverage gaps and streamline access to care rather than to create a controversial policy change.
The main points of potential contention are likely to be the scope of required insurance coverage, the cost impact on insurers and premiums, and the boundary between medically necessary reconstructive care and excluded cosmetic surgery. Insurers may also scrutinize the bill’s broad definitions of congenital anomaly, deviation, and habilitative services, as well as the expedited appeal requirement and the prohibition on practices that could be used to avoid the mandate. Families and patient advocates would likely favor the bill’s expanded benefits and appeal protections, while insurers and possibly employer-sponsored plan sponsors may be concerned about administrative and financial burdens.